Please Wait
Applying Filters...
menu
    • menu
    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-08-25

    Virtual Booth

    An Enquiry

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-08-25

    Virtual Booth

    An Enquiry

    Left Arrow
    Right Arrow

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Dimerix is a clinical-stage biopharmaceutical company leveraging its proprietary Receptor-HIT platform to develop patient-preferred therapies for areas of high unmet need. Our innovative technology identifies novel drug treatments by targeting specific receptor interactions. The lead candidate, DMX-200, is a promising therapy designed to transform the lives of patients with inflammatory kidney and lung diseases. Incorporated i...
    Dimerix is a clinical-stage biopharmaceutical company leveraging its proprietary Receptor-HIT platform to develop patient-preferred therapies for areas of high unmet need. Our innovative technology identifies novel drug treatments by targeting specific receptor interactions. The lead candidate, DMX-200, is a promising therapy designed to transform the lives of patients with inflammatory kidney and lung diseases. Incorporated in 2004, we are focused on commercializing our products for global markets and actively seek strategic collaborations for development and partnering.

    List your booth number for exhibitions, ask us